Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Parkinson's disease
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s by 20%
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, according to a large study. Results showed a 20% to 30% lower risk for these conditions,
Diabetes Drug Linked to 20% Lower Risk of Dementia, Parkinson's
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | Neuroscience
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk for dementia and Parkinson’s disease, a new study finds.
Study links diabetes drugs to lower risk of dementia and Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the .
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
9h
New study to investigate non-invasive treatment for dementia and Parkinson’s
A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
9h
Dementia and Parkinson's 'cure' to be investigated in new first-of-its-kind research
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
2d
on MSN
Types of Alzheimer's disease and how lifestyle choices and regular exercise can help reduce risk
Around 55 million people globally are affected by dementia, with Alzheimer's disease responsible for 70% of these cases. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Alabama mass shooting
Daylight saving time
San Francisco homelessness
Released after guilty plea
Dolphins legend Morris dies
Ga. suspect's mom indicted
Trump to campaign in MI
Sesame Place suit verdict
CA firefighter held for arson
J&J unit files for bankruptcy
No govt. shutdown for now
Iran coal mine blast
PM Modi visits US
Hezbollah rockets hit Israel
Robinson loses key staff
Economic speech this week
CA bill to protect kids online
Free COVID-19 tests
California plastic bag ban
Donlon's homes searched
TN abortion law blocked
Suns broadcaster dies
Drug price challenge revived
Pandas leaving for China
No. 1 at box office again
Biden hosts 'Quad' summit
Former WA governor dies
Boeing defense chief exits
SC 1st execution in 13 years
ISR raids Al Jazeera office
Feedback